|
NDFIP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.042410E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.635800E-02 |
| Normal-vs-Stage2 |
3.949600E-01 |
| Normal-vs-Stage3 |
2.480400E-01 |
| Normal-vs-Stage4 |
4.055000E-01 |
| Stage1-vs-Stage2 |
2.345800E-02 |
| Stage1-vs-Stage3 |
5.811600E-01 |
| Stage1-vs-Stage4 |
4.364000E-01 |
| Stage2-vs-Stage3 |
9.073900E-02 |
| Stage2-vs-Stage4 |
1.418250E-01 |
| Stage3-vs-Stage4 |
8.261000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.480400E-02 |
| Normal-vs-AfricanAmerican |
1.290380E-01 |
| Normal-vs-Asian |
3.262400E-01 |
| Caucasian-vs-AfricanAmerican |
4.627400E-01 |
| Caucasian-vs-Asian |
9.231400E-01 |
| AfricanAmerican-vs-Asian |
5.030000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.444400E-01 |
| Normal-vs-Female |
4.084400E-02 |
| Male-vs-Female |
6.106100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.257760E-02 |
| Normal-vs-Age(41-60Yrs) |
3.658800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.030400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.634600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.116300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.661980E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.741000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.212000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.814200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.199800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.952400E-01 |
| Classical-VS-Follicular |
1.07650000003012E-06 |
| Classical-VS-Other |
2.941400E-01 |
| Classical-VS-Normal |
5.915100E-03 |
| Tall-VS-Follicular |
3.839500E-04 |
| Tall-VS-Other |
1.897430E-01 |
| Tall-VS-Normal |
2.942000E-02 |
| Follicular-VS-Other |
5.772800E-01 |
| Follicular-VS-Normal |
7.347600E-02 |
| Other-VS-Normal |
8.279800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.326600E-01 |
| Normal-vs-N1 |
3.447600E-01 |
| N0-vs-N1 |
2.271000E-01 |
|
|
